The mRNA manufacturing industry has seen a new wave of players pursuing novel plug-and-play approaches, incorporating automation and continuous-flow manufacturing to advance innovation and keep up pace for emerging mRNA applications for new viral strains, novel therapeutic designs and personalized medicine, resulting in a new era of low-cost on-demand mRNA production. 

If you are looking to improve your DNA manufacturing, IVT reaction, analytical characterization, drug product formulation or scale up to GMP level into the clinic and beyond, block your calendar for September 17-19, 2024 to join 200+ technical mRNA experts from large pharma, innovative biotechs and academia at the world’s only industry-led forum to accelerate the end-to-end of mRNA process development and manufacturing for regulatory and market readiness.